Quantcast Jay La Forest's Pharmacy News
Jay La Forest's Pharmacy News By www.FreePharmacyJobs.com
Pharmacy News - The Products And Services That Drive It Forward.
Web | Images | News
News HomeUSWorldBusinessFinanceIndustryTechnologyScienceMedia & AdvertisingPolitics/LawEntertainmentInternetHealthSportsCulture
Jay La Forest's Pharmacy News >> PHARMACEUTICAL INDUSTRY July 04, 2009 members login here
Participate
Build a News Circle
Receive News Briefings
Add this Circle to favorites
Share this News Circle
Subscribe to this News Circle
>>  PHARMACEUTICAL INDUSTRY
Novo Nordisk says Victoza cleared for EU market
Reuters Health - 8 Hours ago
* Diabetes treatment Victoza gets EU marketing approval * Approval was expected after EU drugs agency recommendation * Launch planned for this year and in 2010 * Novo says approval does not change 2009
UPDATE 1-Novo Nordisk says Victoza cleared for EU market FinanzNachrichten.de
Novo Nordisk's diabetes drug Victoza gets European OK Pharma Times
all 4 news articles >>      Add Comment

J&J to acquire Alzheimer's Immunotherapy Programme from Elan
PharmaBiz - 2 Hours ago
Johnson & Johnson and Elan Corporation plc announced a definitive agreement whereby J&J will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Programme
     Add Comment

GSK acquires 13 branded pharma portfolio business from BMS for $23.2 mn
PharmaBiz - 4 Hours ago
GlaxoSmithKline plc (GSK) has acquired the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2 million (14.2m). The business
     Add Comment

K'taka drugs controller issues order to withdraw Rimonabant from all outlets
PharmaBiz - 4 Hours ago
Karnataka drugs control department has issued a circular to stop the production and sales of Rimonabant. This order comes well before the drugs controller general of India circular to all the state departments.
     Add Comment

Pharma industry is worth Rs 78,000 crore: Economic Survey
PharmaBiz - 4 Hours ago
The pharma industry in the country has grown from mere Rs 1500 crore turnover in 1980 to over Rs 78,000 crore in 2008, with about 10 per cent share in the volume of global production, according to the
     Add Comment

'MRAs can help exporters to get faster clearances for trading in pharmaceuticals'
PharmaBiz - 4 Hours ago
The Mutual Recognition Agreements (MRAs) can help the Indian pharma exporters a lot in assuaging regulatory clearances for trading in drugs and other pharmaceutical products. In the area of international
     Add Comment

KAI Pharmaceuticals Buys Patents from Progen
TMC Net - 5 Hours ago
(Close-Up Media via COMTEX) -- KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced the acquisition of an extensive collection of issued and pending patents from
     Add Comment

Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's
Individual.com - 6 Hours ago
Cougar Biotechnology, Inc. (NASDAQ: CGRB) announced today that the initial offering period of Johnson & Johnson's (NYSE: JNJ) tender offer for all the outstanding shares of Cougar common stock expired
Cougar Biotechnology Announces Successful Completion of Johnson & Johnsons Initial Houston Chronicle
Cougar Biotechnology Announces Successful Completion of Johnson & Johnson`s Initial Reuters
all 8 news articles >>      Add Comment

Value-Added Services Suppliers Evolve
Mindbranch - 5 Hours ago
Published Date: June 2009 Published By: IDC Page Count: 6 Order Code: R104-39483 Description This IDC Insight examines recent value-added services announcements made by suppliers and telecom operators.
Added Value Pharmaceutical Services Turns to Active Marketing Services for Creative Pharmacy Choice
Internet, mobile value-added services need fiscal sops Hindu Business Line
all 2 news articles >>      Add Comment

Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
KOTA Territory News - 8 Hours ago
Johnson & Johnson Will Commence Subsequent Offering Period NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced that the initial offering period of its tender offer
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology Individual.com
BRIEF-Johnson & Johnson says completes initial tender offer for Cougar Biotechnology FinanzNachrichten.de
all 3 news articles >>      Add Comment

USCM, Purdue Pharma L.P. Partner to Stop Prescription Drug Abuse
U.S. Mayor Newspaper - 3 Hours ago
USCM, Purdue Pharma L.P. Partner to Stop Prescription Drug Abuse By Crystal Swann During the 77th Annual Meeting, Conference President Miami Mayor Manny Diaz announced a new USCM partnership with the
     Add Comment

WHO to start clinical trial on river blindness drug
Yahoo! Canada - 5 Hours ago
The World Health Organisation said Wednesday it was launching a clinical trial for a drug that could halve the treatment period for river blindness, a disease that threatens 100 million people mostly
Africa Tests New Drug For River Blindness EMax Health
Genentech drug does well in eye test Biz Journals
all 18 news articles >>      Add Comment

::: Silicos, a computational drug design biotech, appoints Dr. Jack Elands as chief
Biotech Intelligence - 5 Hours ago
Belgian biotech to further commercialize its computational fragment based drug design platform as well as its MDM2 and PTP-1B drug development programs. Diepenbeek, Belgium - 3 July 2009 - Today Silicos'
Silicos, a computational drug design biotech, appoints Dr. Jack Elands as chief Pharma Live
all 1 news articles >>      Add Comment

KAI Pharmaceuticals Buys Patents from Progen
TradingMarkets - 5 Hours ago
(Close-Up Media via COMTEX) -- PGLA | Quote | Chart | News | PowerRating -- KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced the acquisition of an extensive
KAI Pharma acquires patents from Progen Bio Spectrum Asia
::: KAI Pharmaceuticals Acquires Patents from Progen, Broadening KAI's Intellectual Biotech Intelligence
all 11 news articles >>      Add Comment

US requires suicide warnings for anti-smoking drugs
Yahoo! Canada - 5 Hours ago
US federal drug regulators on Wednesday required manufacturers to warn against the mental health dangers, including suicidal thoughts, of two popular anti-smoking drugs. The Food and Drug Administration
U.S. orders suicide warnings on two anti-smoking drugs Clackamas Review
Anti-smoking drugs get FDA 'black-box' warning KWCH 12
all 38 news articles >>      Add Comment

Many Factors to Consider When Selecting a Vaccine
AG Weekly Online - 5 Hours ago
NEW YORK - Building immunity and preventing disease are integral parts of achieving dairy wellness on your operation. Incorporating demonstrated vaccines into a well-designed vaccination protocol helps
Pfizer: Many Factors To Consider When Selecting A Vaccine CattleNetwork.com
all 1 news articles >>      Add Comment

US healthcare group buys stake in Irish drug company
Radio New Zealand - 5 Hours ago
Johnson & Johnson is buying a stake in an Irish company developing drugs to treat Alzheimer's disease. The healthcare group is to pay $US1 billion for 18.4% of Elan Corp plc. It will buy rights to most
     Add Comment

Multaq Sanctioned for Heart Rhythm Disorders
HealthScout - 6 Hours ago
THURSDAY, July 2 (HealthDay News) -- Multaq (dronedarone) tablets have been approved by the U.S. Food and Drug Administration to promote a normal heart rhythm in people with atrial fibrillation or atrial
FDA Approves Multaq to Treat Heart Rhythm Disorder KCRG.com
FDA Approves Dronedarone for Atrial Fibrillation or Atrial Flutter Doctors Guide
all 9 news articles >>      Add Comment

BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
KOTA Territory News - 8 Hours ago
TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial
     Add Comment

Johnson & Johnson pays $1 billion for Elan stake
The Brunswick News - 3 Hours ago
TRENTON, N.J. -- Johnson & Johnson, making a big jump into the risky but potentially lucrative field of Alzheimer's disease, is taking a major stake in Irish biopharmaceutical company Elan Corp.,
Johnson & Johnson acquires $1.5B stake in Elan New Jersey Online
Johnson & Johnson pays $1B for Elan stake ABC 7
all 4 news articles >>      Add Comment

FDA reviewing safety of Sanofi's Lantus insulin
Deseret Morning News - 7 Hours ago
TRENTON, N.J. รข?? The Food and Drug Administration said Wednesday it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis SA. The move comes after a recent, widely publicized
FDA to Review Safety of Sanofi's Lantus Wall Street Journal Online
FDA Reviewing Many Sources Of Safety Data For Sanofi's Lantus - Quick Facts RTTNews.com
all 14 news articles >>      Add Comment

Fake Tamiflu out-spams Viagra on Web
CNN - 13 Hours ago
The number of Internet scammers offering fake anti-swine flu drug Tamiflu has surpassed those selling counterfeit Viagra, a UK body said Friday. Since the H1N1 virus, also known as swine flu, was declared
Fake Tamiflu "Out-Spams Viagra On Web" Slashdot
Fake Tamiflu 'out-spams Viagra on Web' CNN
all 2 news articles >>      Add Comment

Elan takeover more likely after Johnsons deal
Morningstar UK - 16 Hours ago
Elan and Johnson & Johnson's stake deal has made an outright acquisition of our top ranked biotech takeover candidate more plausible Johnson & Johnson is taking a major stake in Elan Corp in order to
     Add Comment

UPDATE 1-J&J says 84.4 pct of Cougar shares tendered
Reuters - 18 Hours ago
* Says about 17.7 mln shares tendered * Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson (JNJ.N) said about 84.4 percent
UPDATE 1-J&J says 84.4 pct of Cougar shares tendered CNBC
all 1 news articles >>      Add Comment

Dedicated pharma hub planned for Total Processing & Packaging
Manufacturing Chemist - 11 Hours ago
Skip to [ Story Content and jump story attachments ] Printable version E-mail to a friend External weblinks Manufacturing Chemist is not responsible for the content of external internet sites. - - - -
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?
Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.